Please login to the form below

Not currently logged in
Email:
Password:

EMEA and FDA collaboration

The European Medicines Agency and the US Food and Drug Administration have announced a Good Clinical Practice initiative

The European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) have announced a Good Clinical Practice (GCP) initiative. The two organisations will collaborate on inspections and share information on planning policy and outcomes. The aim is to ensure that clinical trials, conducted as part of the marketing authorisation process, are safe, ethical, appropriate and uniform. 

Thomas Lönngren, executive director of EMEA said in a statement that the project "marks an important step to the building of a global regulatory network for supervision of clinical trials". 

Commissioner of Food and Drugs at the FDA, Margaret Hamburg commented:

"Collaboration with international allies like the EMEA will lead to exciting opportunities for progress in public health… This important effort will help to strengthen safeguards for participants and others involved in clinical studies."

An 18-month pilot phase will begin on September 1 2009.

4th August 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics